Slideshow
Agents that target the TH17-interleukin pathway show promise in psoriatic arthritis, as alternatives for patients who don't benefit from TNFα blockers. This slide show describes their mode of action and potential.
People With Fibromyalgia May Have Impaired Mitochondrial Function
Emerging Agents in the Treatment of Rheumatic Diseases
JAKi Treatment for Psoriatic Arthritis Not Associated With Increased CVD, VTE, Cancer Risk
Challenges with Step Therapy Protocols in Treating Rheumatoid Arthritis
Cluster Headache Often Comorbid with Fibromyalgia, Migraine
Research Confirms Cold Therapy Benefits During Gout Flares